Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 7/20 | 0.52 |
| ▸ | CES2 | O00748 | 7/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | DAO | P14920 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4953144 | 0.85 | CES1 (0.44) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| SCHEMBL1632835 | 0.83 | TDP1 (0.55) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| SCHEMBL18687120 | 0.80 | TDP1 (0.57) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| SCHEMBL30863826 | 0.78 | TDP1 (0.55) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| SCHEMBL4019209 | 0.75 | CES1 (0.48) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| SCHEMBL22204644 | 0.75 | CES1 (0.48) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| SCHEMBL274249 | 0.75 | CES1 (0.48) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| Benzamide SCHEMBL27340650 | 0.72 | PARP1 (0.89) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| Benzamide SCHEMBL28132124 | 0.72 | PARP1 (0.89) | TDP1TSHRCYP3A4MAPTHSD17B10 | |
| Benzamide SCHEMBL2061911 | 0.72 | PARP1 (0.89) | TDP1TSHRCYP3A4MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 660 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734894-A2 | POLYMER COMPOSITIONS AND USES THEREOF | The University of Melbourne (AU) | 2026-05-06 | — | — | EP | claimed |
| WO-2025006821-A9 | POLYMER COMPOSITIONS AND USES THEREOF | THE UNIVERSITY OF MELBOURNE (AU) | 2026-04-30 | — | — | WO | claimed |
| EP-4656661-A1 | BLOCK COPOLYMERS SUITABLE AS IMPACT MODIFIERS, PROCESS FOR THEIR PREPARATION AND POLYMERIZABLE MATERIALS COMPRISING THEM | Ivoclar Vivadent AG (LI) | 2025-12-03 | — | — | EP | claimed |
| EP-4574181-A2 | BIOADHESIVE FOR CORNEAL REPAIR | The Brigham and Women's Hospital Inc. (US) | 2025-06-25 | — | — | EP | claimed |
| US-12319820-B2 | Process and material for producing 3D objects by energy-pulse-induced transfer printing | IVOCLAR VIVADENT AG (LI) | 2025-06-03 | — | — | US | claimed |
| EP-3413940-B1 | BIOADHESIVE FOR CORNEAL REPAIR | BRIGHAM & WOMENS HOSPITAL INC (US) | 2025-05-07 | — | — | EP | claimed |
| EP-4085893-B1 | TRANSPARENT, FRACTURE-RESISTANT POLYMERISATION RESINS FOR THE PRODUCTION OF DENTAL MOULDINGS | IVOCLAR VIVADENT AG (LI) | 2025-02-26 | — | — | EP | claimed |
| CN-115300400-B | Transparent, fracture-tough polymeric resins for the production of dental molded bodies | 义获嘉伟瓦登特公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2025006821-A2 | POLYMER COMPOSITIONS AND USES THEREOF | THE UNIVERSITY OF MELBOURNE (AU) | 2025-01-02 | — | — | WO | claimed |
| US-20240423878-A2 | SELF-ADHESIVE FISSURE SEALANT | KULZER GMBH (DE) | 2024-12-26 | — | — | US | claimed |
| US-20180171052-A1 | Polymer-based burn-out material for the lost-wax technique | IVOCLAR VIVADENT AG (LI) | 2018-06-21 | — | — | US | claimed |
| EP-3335687-A1 | FIREABLE DENTAL MODELLING MATERIAL | Ivoclar Vivadent AG (LI) | 2018-06-20 | — | — | EP | claimed |
| WO-2017139318-A1 | BIOADHESIVE FOR CORNEAL REPAIR | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2017-08-17 | — | — | WO | claimed |
| US-9387056-B2 | Process for producing a dental shaped part by stereolithography | IVOCLAR VIVADENT AG (LI) | 2016-07-12 | — | — | US | claimed |
| US-20150111176-A1 | COMPOSITE RESIN COMPOSITION AND USE THEREOF, METHOD FOR PRODUCING DENTAL COMPONENTS BY MEANS OF STEREO-LITHOGRAPHY | IVOCLAR VIVADENT AG (LI) | 2015-04-23 | — | — | US | claimed |
| CN-104246606-A | COMPOSITE RESIN COMPOSITION AND METHOD FOR PRODUCING DENTAL COMPONENTS BY MEANS OF STEREO-LITHOGRAPHY | IVOCLAR VIVADENT AG | 2014-12-24 | — | — | CN | claimed |
| US-20140357425-A1 | GOLF BALL WITH VISIBLE LIGHT-CURED COATING AND METHOD | NIKE, INC. | 2014-12-04 | — | — | US | claimed |
| WO-2014193679-A1 | GOLF BALL WITH VISIBLE LIGHT-CURED COATING AND METHOD | NIKE INNOVATE C.V. (US) | 2014-12-04 | — | — | WO | claimed |
| EP-2751618-A2 | COMPOSITE RESIN COMPOSITION AND METHOD FOR PRODUCING DENTAL COMPONENTS BY MEANS OF STEREO-LITHOGRAPHY | Ivoclar Vivadent AG (LI) | 2014-07-09 | — | — | EP | claimed |
| WO-2013153183-A2 | COMPOSITE RESIN COMPOSITION AND METHOD FOR PRODUCING DENTAL COMPONENTS BY MEANS OF STEREO-LITHOGRAPHY | IVOCLAR VIVADENT AG (LI) | 2013-10-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240423878-A2 | SELF-ADHESIVE FISSURE SEALANT | ESD, GFER, FUS | TDP1 563/4885TSHR 1186/4885CYP3A4 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.